SCHEMBL24601752

SCHEMBL24601752

N#Cc1cccc2c3c4c5ccccc5n5c6c(C#N)cccc6c(c6c7ccccc7n(c12)c63)c45

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 2/20 0.42
ALDH1A1 P00352 5/20 0.40
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 2/20 0.37
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
STAT3 P40763 1/20 0.36
KDM4E B2RXH2 3/20 0.35
HTT P42858 2/20 0.35
HSD17B10 Q99714 1/20 0.35
RAB9A P51151 2/20 0.34
IMPDH1 P20839 1/20 0.33
GAA P10253 1/20 0.33
GALR3 O60755 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601750 0.85 IMPDH2 (0.41) IMPDH2ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL24524252 0.76 IMPDH2 (0.37) IMPDH2ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL21570098 0.74 KDM4E (0.43) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL18030919 0.74 GPR3 (0.52) IMPDH2ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL17032702 0.74 ALKBH5 (0.58) IMPDH2ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL24601755 0.73 KDM4E (0.34) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL18030937 0.72 KDM4E (0.50) IMPDH2ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL18028322 0.72 IMPDH2 (0.46) IMPDH2ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL20857974 0.72 KDM4E (0.45) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL26261208 0.72 KDM4E (0.45) ALDH1A1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 IMPDH2 1215/4885ALDH1A1 3824/4885MAPT 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.